Healthcare Analysts the launch of GE Healthcare Technologies’ Alzheimer’s Disease LEQEMBI and expected launch of donanemab, pace and outlook, imaging requirements in practice compared to labeling and insights on capacity shortages and capital outlook on an Analyst/Industry conference call to be held on July 28 at 11 am.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on GEHC:
- Mizuho healthcare analysts hold an analyst/industry conference call
- GE HealthCare sees FY23 free cash flow conversion of 85% or more
- GE HealthCare raises FY23 adjusted EPS view to $3.70-$3.85 from $3.60-$3.75
- GE HealthCare reports Q2 adjusted EPS 92c, consensus 87c
- Notable companies reporting before tomorrow’s open